Difficulties in the differential diagnosis of erythema nodosum: Primary myelofibrosis as an etiological factor
https://doi.org/10.14412/1996-7012-2017-2-54-56
Abstract
Erythema nodosum (EN) is the most common form of panniculitis that is a reactive process caused by a wide variety of etiological factors. The problems with the differential diagnosis of this abnormality have not lost its relevance. The paper deals with a clinical case of recurrent EN concurrent with an immunological phenomenon (positivity for rheumatoid factor and antimitochondrial antibodies), long-lasting asymptomatic splenomegaly, and subsequently developed primary myelofibrosis. To ascertain the cause of secondary EN often causes difficulties in real clinical practice.
About the Authors
D. I. Abdulganieva
Kazan State Medical University, Ministry of Health of Russia, Kazan
Russian Federation
Russian Federation
I. F. Fayrushina
Kazan State Medical University, Ministry of Health of Russia, Kazan
Russian Federation
Russian Federation
E. V. Sukhorukova
Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan
Russian Federation
Russian Federation
I. L. Serdyuk
Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan
Russian Federation
Russian Federation
M. A. Kunst
Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan
Russian Federation
Russian Federation
R. Z. Abdrakipov
Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan
Russian Federation
Russian Federation
M. A. Afanasyeva
Republican Clinical Hospital, Ministry of Health of the Republic of Tatarstan, Kazan
Russian Federation
Russian Federation
References
1. Requena L, Yus SE. Erythema nodosum. Semin Cutan Med Surg. 2007 Jun;26(2):114-25.
2. Chowaniec M, Starba A, Wiland P. Erythema nodosum – review of the literature. Reumatologia. 2016;54(2):79-82. doi: 10.5114/reum.2016.60217. Epub 2016 Jun 3.
3. Гришаева ТП, Белов БС. Узловатая эритема. Русский медицинский журнал. 2005;(8):565-9. [Grishaeva TP, Belov BS. Erythema nodosum. Russkii meditsinskii zhurnal. 2005;(8):565-9. (In Russ.)].
4. Bohn S, Bü chner S, Itin P. Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr. 1997, Jul 8;127(27-28):1168-76.
5. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood. 2007 Aug 15;110(4):1092-7. Epub 2007 May 8.
6. Gordon BR, Coleman M, Kohen P, Day NK. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood. 1981 Nov;58(5):904-10.
7. Cho SH, Xu M, Roboz J, et al. The effect of CXCL 12 Processing on CD 34+Cell Migration in Myeloproliferative Neoplasms. Cancer Res. 2010 Apr 15;70(8):3402-10. doi: 10.1158/0008-5472.CAN-09-3977. Epub 2010 Apr 13.
8. Schmitt A, Helene J, Josette G, et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood. 2000 Aug 15;96(4):1342-7.
9. Massa M, Rosti V, Ramajoli I, et al. Circulating CD 34+, CD 133+ and Vascular endothelial Growth FactorReceptor-2 Positive Endothelial Progenitor Cells in Myelofibrosis with Myeloid Metaplasia. J Clin Oncol. 2005 Aug 20;23(24):5688-95.
10. De Simone C, Caldarola G, Scaldaferri F, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016 May;55(5):e289-94. doi: 10.1111/ijd.13212. Epub 2016 Feb 24.
11. Llorente L, Richaud-Patin Y, Alvarado C, et al. Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw. 1997 Mar;8(1):67-71.
Review
For citations:
Abdulganieva DI, Fayrushina IF, Sukhorukova EV, Serdyuk IL, Kunst MA, Abdrakipov RZ, Afanasyeva MA. Difficulties in the differential diagnosis of erythema nodosum: Primary myelofibrosis as an etiological factor. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2017;11(2):54-56. (In Russ.) https://doi.org/10.14412/1996-7012-2017-2-54-56
Views:
3714
Email this article 